Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Anna Jo Bodurtha, Smith"'
Publikováno v:
Gynecologic Oncology Reports, Vol 52, Iss , Pp 101335- (2024)
Objectives: PARP inhibitors (PARP-I) improve survival in ovarian cancer, especially in patients with germline or somatic BRCA mutations or other homologous recombination deficiency (HRD). With high efficacy and costs, insurers may enact barriers or f
Externí odkaz:
https://doaj.org/article/3167e979ba3245dbb1fdc03276bf5080
Autor:
Daniel H. Saris, Daniella Pena, Ashley F. Haggerty, Neil K. Taunk, Emily M. Ko, Anna Jo Bodurtha Smith
Publikováno v:
Gynecologic Oncology Reports, Vol 47, Iss , Pp 101177- (2023)
Delays in starting potentially curative treatment for locally-advanced cervical cancer (LACC) decrease survival. Reasons for these delays are poorly understood. We conducted a retrospective chart review examining disparities in time from diagnosis of
Externí odkaz:
https://doaj.org/article/58413237d11f4835b93ce5c0ef747a59
Autor:
Anna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, Genevieve P. Kanter, Justin E. Bekelman, Ashley Haggerty, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 46, Iss , Pp 101159- (2023)
While prior authorization aims to reduce unnecessary care, it may limit or delay medically necessary care. Delays in cancer care can impact survival and are more common in historically-marginalized populations. Our objective was to examine to what ex
Externí odkaz:
https://doaj.org/article/e2454eec443542299513e7d7c7d54355
Autor:
Daniel H. Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, Sarah H. Kim, Ashley F. Haggerty, Nawar Latif, Lori Cory, Robert L. Giuntoli, Mark A. Morgan, Lilie L. Lin, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100922- (2022)
Objectives: To examine overall survival (OS) and cancer-specific survival (CSS) for different racial groups of women with surgically staged endometrial cancer by histologic subtype. Methods: This is a retrospective cohort study of women with stage I-
Externí odkaz:
https://doaj.org/article/9b56877f403f46559c5972e8eef9533b
Autor:
Anna Jo Bodurtha, Smith, Lakeisha, Mulugeta-Gordon, Daniella, Pena, Genevieve P, Kanter, Justin E, Bekelman, Ashley E, Haggerty, Emily M, Ko
Publikováno v:
Gynecologic Oncology. 167:519-522
Prior authorization was designed to minimize unnecessary care and reduce spending but has been associated with delays in necessary care. Our objective was to estimate the occurrence of prior authorization, and impact on cancer care, in gynecologic on
Publikováno v:
Journal of Lower Genital Tract Disease. 27:29-34
The aim of the study are to compare trends in diagnosis and treatment of adenocarcinoma of the cervix (AC) to squamous cell carcinoma of the cervix (SCC) and to examine associations between stage at diagnosis and guideline-concordant treatment with r
Autor:
Anna Jo Bodurtha Smith, R. Annetta Zhou, Emilie Sites, Sara E. Hallvik, David M. Cutler, Alyna T. Chien
Publikováno v:
American Journal of Obstetrics and Gynecology. 227:108-111
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 32(6)
ObjectiveTo identify patient, clinical and hospital factors associated with long-term survival (≥10 years) in women with serous ovarian cancer.MethodsThis National Cancer Database cohort study included women with stage II–IV serous ovarian cancer
Publikováno v:
American Journal of Obstetrics and Gynecology. 228:98-100.e1
Publikováno v:
Obstetrics and gynecology. 139(6)
The Affordable Care Act's (ACA) 2014 Medicaid expansion is associated with gains in insurance and early-stage diagnosis among patients with gynecologic cancer, but its association with mortality remains unknown. This study aims to assess whether the